| Medical and Health Sciences | 2021-2025 | 660 | IT 47 | 99.86 |
| Internal Medicine | Lifetime | 9 | IT 1 | 99.72 |
| Cardiology and Cardiovascular Medicine | Lifetime | 383 | IT 22 | 99.51 |
| Hematology | Lifetime | 548 | IT 32 | 95.98 |
| Clinical Neurology | Lifetime | 959 | IT 38 | 93.68 |
| Hepatology | Lifetime | 720 | IT 54 | 87.63 |
| Internal Medicine | 2021-2025 | 4 | IT 1 | 99.45 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 354 | IT 21 | 96.15 |
| Surgery | 2021-2025 | 780 | IT 55 | 93.08 |
| Medical Genetics | 2021-2025 | 267 | IT 26 | 84.93 |
| Hepatology | 2021-2025 | 307 | IT 31 | 77.84 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 29 | IT 3 | 99.83 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 45 | IT 2 | 99.83 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 44 | IT 4 | 99.42 |
| Central Venous Catheters and Hemodialysis | Lifetime | 43 | IT 4 | 99.50 |
| Cerebral Venous Sinus Thrombosis | Lifetime | 32 | IT 1 | 99.32 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 52 | IT 2 | 98.87 |
| Acute Ischemic Stroke Management | Lifetime | 311 | IT 5 | 99.04 |
| COVID-19 Clinical Research Studies | Lifetime | 558 | IT 61 | 97.90 |
| Case Reports on Hematomas | Lifetime | 19 | IT 1 | 98.59 |
| COVID-19 and healthcare impacts | Lifetime | 236 | IT 30 | 96.58 |
| Cardiac tumors and thrombi | Lifetime | 181 | IT 22 | 98.13 |
| Acute Myocardial Infarction Research | Lifetime | 423 | IT 25 | 98.68 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 446 | IT 43 | 97.99 |
| Ultrasound in Clinical Applications | Lifetime | 409 | IT 37 | 95.44 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 204 | IT 18 | 95.82 |
| Vitamin K Research Studies | Lifetime | 209 | IT 10 | 93.97 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 744 | IT 18 | 94.77 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 589 | IT 36 | 86.73 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 14 | IT 1 | 99.66 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 50 | IT 4 | 99.41 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 17 | IT 3 | 98.10 |
| Cerebral Venous Sinus Thrombosis | 2021-2025 | 40 | IT 1 | 96.00 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 120 | IT 13 | 93.85 |
| Diagnosis and Treatment of Venous Diseases | 2021-2025 | 66 | IT 4 | 94.55 |
| COVID-19 and healthcare impacts | 2021-2025 | 709 | IT 51 | 91.03 |
| Case Reports on Hematomas | 2021-2025 | 15 | IT 3 | 91.90 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 127 | IT 14 | 93.55 |
| Liver Disease and Transplantation | 2021-2025 | 626 | IT 69 | 94.41 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 408 | IT 55 | 91.26 |
| Acute Myocardial Infarction Research | 2021-2025 | 746 | IT 75 | 91.80 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 195 | IT 17 | 82.51 |
| Vitamin K Research Studies | 2021-2025 | 192 | IT 14 | 65.27 |